Cytosorbents Corp revenue
Cytosorbents Corp's revenue was $37.1m in fiscal 2025, up 4.1% on the year before. Since fiscal 2011 ($36,078) it has grown at a compound 64.1% a year. Over the last twelve months it was $37.2m.
Revenue history
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 2 | 4 | 5 | 10 | 15 | 23 | 25 | 41 | 43 | 35 | 31 | 36 | 37 | 37 |
| Growth on the year before | — | +>999% | +80.4% | +70.2% | +16.2% | +98.8% | +59.0% | +48.5% | +10.9% | +64.4% | +5.3% | −19.6% | −10.4% | +14.5% | +4.1% | — |
| Gross profit | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 15 | 18 | 30 | 32 | 21 | 22 | 25 | 26 | 27 |
| Gross margin | 67.4% | 76.2% | 21.1% | 48.2% | 53.8% | 58.5% | 63.6% | 66.7% | 70.5% | 73.0% | 74.4% | 59.8% | 70.6% | 69.9% | 71.5% | 71.6% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Cytosorbents Corp | $37.2m | 3.1% | 0.8% |
| Electrocore, Inc. | $37.0m | 33.5% | 50.4% |
| Utah Medical Products Inc | $36.1m | -7.0% | -11.4% |
| Retractable Technologies Inc | $33.9m | -11.2% | -14.7% |
| Myomo, Inc. | $43.3m | 6.1% | 35.4% |
| Orchestra Biomed Holdings, Inc. | $32.0m | 986.1% | 94.5% |
Compare with peers
- Electrocore, Inc. revenue
- Utah Medical Products Inc revenue
- Retractable Technologies Inc revenue
- Myomo, Inc. revenue
- Orchestra Biomed Holdings, Inc. revenue
Head to head: CTSO vs ECORCTSO vs UTMDCTSO vs RVP
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies